Prospection partners with leading Japanese healthcare data provider Medical Data Vision to improve treatment access for patients

Prospection | September 06, 2022 | Read time : 04:00 min

Prospection partners

Health analytics pioneer, Prospection has announced a unique global data access agreement with leading Japanese medical data company Medical Data Vision Co., Ltd. to accelerate healthcare analytics globally.

The agreement, covering the world's second largest pharmaceutical market, will provide global pharmaceutical companies and researchers access to comprehensive and longitudinal data covering more than 40 million people in Japan at more than 470 hospitals.

Combining  predictive analytics and machine learning with real-world healthcare data, Prospection's agreement with MDV will provide pharmaceutical companies across the world with unique access to patient diagnostic and medication data from hospitals across Japan, unlocking potential to assess an unlimited number of treatment programs in the region.

The agreement  also enables access to patient history and prefecture level data, allowing analysis of disease progression, disease outcomes and the mapping of disease courses to provide evidence on areas where development can address unmet needs.  When distilled further, this creates an opportunity to assess patient data on a regional level to find geographical areas where patients or health centres require additional support for specific disease and conditions.

Prospection's access to Japan's most comprehensive medical data sets is a significant milestone for the company. Prospection currently provides real-time access to longitudinal patient data across 15 regions globally including Australia, New Zealand, Japan, South Korea, Taiwan, USA and the UK. The company's latest announcement with Medical Data Vision will build on this work, providing Prospection with access to one of Japan's largest healthcare databases.

"We are delighted to announce our latest agreement with Medical Data Vision. This partnership demonstrates a shared commitment to improving patient outcomes and marks a significant milestone in Prospection's mission to deliver real community benefits to patients across the globe.

"As one of the largest pharmaceutical markets in the world, Japan has incredibly rich datasets. Working with Medical Data Vision gives us the opportunity to access a dataset of approximately 40 million patients, creating a unique opportunity to use advanced analytic tools to accelerate precision medicine to enable the right patient to receive the right treatment at the right time in their journey.

"The outcomes of this partnership will play a key role in understanding the full cycle of patient health conditions and disease journeys in areas including immuno-oncology, immune disorders, cardiovascular and metabolic conditions  allowing researchers and pharmaceutical companies globally to better understand the different patient characteristics, treatments and respective outcomes."

Eric Chung, CEO and Co-founder, Prospection

"We are very excited to be working with MDV in our latest data access agreement. Combining MDV's large and comprehensive dataset with Prospections global reach and extensive expertise working with datasets across the world will not only allow MNC pharmaceutical companies to work with patient data from Japan, but will also open a broader understanding of different health conditions across the world. This agreement brings us one step closer to enhancing precision medicine to find the 40% of patients that can be optimised."

About Prospection
Prospection is a pioneer in health data analytics technology.  We are on a mission to make advancements to precision medicine through real world evidence, with an aim to put the right patient on the right treatment at the right time.  Applying advanced ML algorithms to real-world data we unearth health journey and treatment insights by analysing longitudinal data for hundreds of millions of patients to see how drug treatments are used after the clinical trial. Delivering actionable real-world evidence that enables better outcomes for patients, across the world.

Prospection is guided by credentialled experts and innovative leaders within their respective fields. Globally, we work with over 15 large health data sets applying our expertise to examine health patterns.  Working with government and researchers through to our core client base in the pharma/biopharmaceutical industry, we have delivered insights across more than 90 therapeutic indications.  Including rare and complex diseases such as oncology, immuno-oncology, virology, metabolic conditions, respiratory and cardiovascular disease. Prospection is backed by investors including Ellerston, Horizons Ventures and Main Sequence, and commercially with CRO Novotech.

About Medical Data Vision (MDV)
MDV is an accumulation of anonymously processed data with secondary usage permission from medical institutions. The actual number of patients in the "hospital data" centered on the acute phase is 40.42 million. In addition, by holding data from the health insurance association, data on the recovery period and chronic period has been enhanced, and in addition to information by hospital/clinic, it has become possible to track information on transfer destinations. "Health insurance data" was 7.84 million people (same).


In 2020 the world changed as we know it. The COVID-19 pandemic brought into sharp focus the vulnerabilities that exist in many healthcare systems. Healthcare providers had to quickly adapt their service delivery models, consider future possible scenarios, and continue to innovate.


In 2020 the world changed as we know it. The COVID-19 pandemic brought into sharp focus the vulnerabilities that exist in many healthcare systems. Healthcare providers had to quickly adapt their service delivery models, consider future possible scenarios, and continue to innovate.

Related News


Cognosos to Provide Siemens Healthineers with Next-Generation Technology to Power Real-Time Location Services for its Customer Network of Hospitals

Businesswire | April 19, 2023

Cognosos – a leading provider of real-time location services announced it has been selected by Siemens Healthineers to provide real-time asset tracking and intelligence for hospitals and healthcare systems. With this strategic relationship, Siemens Healthineers becomes an important reseller of the Cognosos portfolio of products and services. Designed to track the location of critical mobile medical equipment, Cognosos technology enables healthcare facilities to streamline operations, uncover hidden costs and improve staff satisfaction and patient experience. “Enhancing our customers' ability to optimize operations and maximize productivity with real-time, room-level visibility of their assets using easily deployed, lightweight infrastructure will be a significant workflow and efficiency driver for healthcare providers,” said Ben Sperling, Vice President and GM of Enterprise Intelligence, Enterprise Services, North America, Siemens Healthineers. Unlike the hardware-heavy and operationally disruptive solutions of the past, RTLS from Cognosos leverages advancements in AI and cloud to drastically reduce the hardware footprint and associated installation challenges required for real-time asset tracking, while delivering a more complete set of data through the provision of both macro (site-wide) and micro (room-level) visibility. “Our ability to provide next-generation visibility and insights—without the burdensome installation and expensive price tag associated with legacy RTLS technology—was important to Siemens Healthineers,” said Cognosos CEO, Braxton Jarratt. “This collaboration will enable hospitals to quickly and easily implement RTLS while providing the intelligence needed to accelerate processes and streamline operations within their facilities.” Cognosos’ RTLS platform is built on patented, long-range wireless networking technology and Cognosos LocationAI™, a proprietary AI-powered location engine that enables both site-wide and room-level visibility. This combination of advanced technology enables seamless tracking across patient treatment rooms and common areas without the need for additional equipment. Cognosos delivers a more complete set of insights to drive evidence-based decisions and a hard-dollar ROI in a fraction of the time of competitors’ solutions. About Cognosos Cognosos is paving the way for the next generation of real-time location systems (RTLS). Supporting the biggest brands in industries like healthcare, automotive, logistics and manufacturing, Cognosos technology has been used to track over 5 million assets. Cognosos' cloud-based software, and ultra-lightweight footprint delivers an unparalleled combination of price and performance, reducing time-to-value, increasing ROI and eliminating the traditional deployment barriers of legacy systems.

Read More


Inovaare launches Usher, a Generative AI-Powered Compliance Assistant for Healthcare Payers and Providers

Prweb | May 26, 2023

Inovaare Corporation, an industry-leading healthcare compliance and operations management software provider, today announced the launch of Usher, a generative AI-powered Compliance assistant designed to simplify complex compliance content for the healthcare industry. Usher combines the power of conversational AI, Natural Language Processing (NLP), and deep learning to provide a whole new experience that would transform and accelerate Compliance Department as well as business user productivity. Usher can work across various operational users of a healthcare payer or provider organization to assist analyzing regulatory requirements, provide summarized policy/procedure content, and respond to any regulatory standards. Usher responds to queries conversationally and remembers previous conversations — all while sustaining privacy and security requirements. The models powering Usher are heavily trained on regulatory content and context, making it enterprise-ready to securely deliver AI at scale. It is currently being used for Medicare regulatory guidelines, CMS notices, such as HPMS memos, as well as organizational Policies & Procedures. "Usher will fundamentally transform the work of every user as it enhances their ability to adhere to compliance requirements that improve overall member experience,” said Pravat Rout, CEO of Inovaare Corporation. “Our mission is to empower users to manage compliance requirements effectively, so we integrated Usher with our Compliance Operating Platform as well as our GRC and Appeals & Grievances solutions, for added functionality and benefits." About Inovaare Corporation Inovaare helps health plans improve member experience by simplifying the regulatory compliance requirements and providing best practices through its industry-leading compliance operating platform, which automates complex regulatory processes and enables composable solutions that access data across internal and external departments, creating one compliance management ecosystem. Inovaare's comprehensive suite of HIPAA-compliant solutions, built on top of its HITRUST-certified platform, empowers healthcare organizations to efficiently meet their unique business requirements, sustain audit readiness through continuous monitoring, reduce non-compliance risks, lower operating costs and improve overall member experience.

Read More


CarepathRx Health System Solutions and Evernorth Health Services Forge Strategic Partnership to Enhance Specialty Care for Patients

PRNewswire | June 02, 2023

CarepathRx Health System Solutions, a CarepathRx company and portfolio company of Nautic Partners (Nautic), and Evernorth Health Services, a subsidiary of The Cigna Group announced a new strategic partnership and investment by Evernorth in CHSS. The strategic partnership brings together Evernorth's diverse specialty and care expertise with CHSS' robust pharmacy and infusion management capabilities, technology solutions, and health system relationships to improve, expand, and accelerate pharmacy care delivery for the growing number of patients with chronic and complex care needs. The CHSS and Evernorth partnership will deliver integrated specialty pharmacy care to CHSS' growing base of 600-plus hospitals, health systems, and physicians – helping diversify the services they offer to best support patients. This includes enhanced coordinated infusion services, virtual care capabilities, value-based care arrangements, and site of care flexibility. Evernorth's expansive suite of services, including Accredo's specialty care and pharmacy expertise and CuraScript SD's specialty medication distribution across 12,000 physicians, is highly complementary to CHSS' capabilities that help health systems expand in-house specialty pharmacies, infusion and polypharmacy services. "Forging deeper relationships with physicians and other specialty and infusion pharmacies – a critical point of care for people with chronic and complex needs – is a key priority as we work to increase access to care and improve affordability," said Eric Palmer, President and CEO, Evernorth. "Specialty care continues to be a focal point for hospital, health system, and physician partners, and our collaboration with CHSS is an important step in delivering on our commitment to bring them even more patient care services to improve overall outcomes." Together, over time, CHSS' and Evernorth's expertise will help enable simpler, faster connections to care for patients managing chronic and complex specialty conditions. As many of these patients need specialty or acute drug therapies, the partnership will focus on continuity of care for specialty drugs, management of infusion services across sites of care – from ambulatory to physician office to home settings – and value-based site-of-care strategies. The intent is to drive optimal patient treatment plans and deepen physician engagement, resulting in better patient experiences, more care extensions, and greater affordability. "At CarepathRx, we believe health systems, hospitals, and physicians play the most important roles in providing the best care to patients with chronic and complex diseases," said John Figueroa, Chairman and CEO, CarepathRx. "Through specialty and infusion pharmacy partnerships, CHSS has created a model for health systems to extend their reach to alternate sites of care and into the home. This partnership with Evernorth is truly unique and will accelerate CHSS' mission by creating payer-physician connections and leveraging Evernorth's specialty and care services." Centerview Partners acted as lead financial advisor and Cantor Fitzgerald is also acting as financial advisor to CarepathRx and Nautic. Kirkland & Ellis LLP acted as legal advisor to CarepathRx and Nautic. Greenhill & Co. acted as financial advisor to Evernorth. Wachtell, Lipton, Rosen & Katz and Quarles & Brady LLP acted as legal advisors to Evernorth. About CarepathRx CarepathRx is transforming pharmacy care delivery for health systems and hospitals, delivering improved patient outcomes that drive clinical, quality, and financial results. Through the industry's most comprehensive, end-to-end hospital pharmacy care delivery model, CarepathRx is turning hospital pharmacy into an active care management strategy and revenue generator while providing support across the patient's complete healthcare journey. The company takes an enterprise approach, providing a powerful combination of technology, market-leading clinical pharmacy services, and wrap-around services that optimize pharmacy performance across the enterprise for fully integrated pharmacy operations, expanded healthcare services, improved ambulatory access, minimized clinical variation, and new health system revenue streams. Today, CarepathRx serves more than 25 health systems and 600 hospitals, with more than 1,500 employees nationwide.

Read More